Altana buys Eckhart in $768M buyout

Germany's Altana has struck a deal to buy Eckhart, a chemical and pigments maker, for $768 million. After the buyout is complete, Altana plans to spin off the company as Altana Chemie. The deal should be completed by the end of the year.

- read this story from the AP for more

Suggested Articles

Rachel Humphrey, M.D., who joined CytomX as chief medical officer after heading immuno-oncology at AstraZeneca and Eli Lilly, has made her exit.

Scientists have discovered a scorpion toxin could inspire treatments to block the inflammation that triggers chronic pain.

The phase 2 success keeps Hal Barron’s group on track to file for approval in multiple myeloma by the end of the year.